Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Myelodysplastic syndromes clinical practice guidelines in oncology.

Greenberg PL, Baer MR, Bennett JM, Bloomfield CD, De Castro CM, Deeg HJ, Devetten MP, Emanuel PD, Erba HP, Estey E, Foran J, Gore SD, Millenson M, Navarro WH, Nimer SD, O'Donnell MR, Saba HI, Spiers K, Stone RM, Tallman MS.

J Natl Compr Canc Netw. 2006 Jan;4(1):58-77. No abstract available. Erratum in: J Natl Compr Canc Netw. 2006 Mar;4(3):table of contents. Dosage error in article text.

PMID:
16403405
2.

Focus on myeloproliferative diseases and myelodysplastic syndromes.

Van Etten RA, Shannon KM.

Cancer Cell. 2004 Dec;6(6):547-52. Review. No abstract available.

3.

[Myelodysplastic diseases in childhood].

Niemeyer C, Stollmann-Gibbels B, Ebell W, Gaedicke G, Creutzig U.

Klin Padiatr. 1992 Jul-Aug;204(4):190-7. Review. German.

PMID:
1518255
4.

The myelodysplastic syndromes: diagnostic criteria and laboratory evaluation.

Ho PJ, Gibson J, Vincent P, Joshua D.

Pathology. 1993 Jul;25(3):297-304. Review. No abstract available.

PMID:
8265251
5.
6.

[Myelodysplastic syndrome].

Urabe A.

Gan To Kagaku Ryoho. 2005 Mar;32(3):287-91. Review. Japanese.

PMID:
15791810
7.

Myelodysplastic and myeloproliferative disorders in children.

Hasle H.

Curr Opin Pediatr. 2007 Feb;19(1):1-8. Review.

PMID:
17224655
8.

Advances in the management of low- to intermediate-risk myelodysplastic syndrome: Integrating the National Comprehensive Cancer Network guidelines.

Kurtin SE.

Clin J Oncol Nurs. 2006 Apr;10(2):197-208. Review. Erratum in: Clin J Oncol Nurs. 2007 Apr;11(2):186.

PMID:
16708703
9.

Myelodysplastic syndromes: recent advances.

Alessandrino EP, Amadori S, Cazzola M, Locatelli F, Mecucci C, Morra E, Saglio G, Visani G, Tura S.

Haematologica. 2001 Nov;86(11):1124-57. Review. No abstract available. Erratum in: Haematologica 2001 Dec;86(12):1323.

10.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.

Oliansky DM, Antin JH, Bennett JM, Deeg HJ, Engelhardt C, Heptinstall KV, de Lima M, Gore SD, Potts RG, Silverman LR, Jones RB, McCarthy PL Jr, Hahn T.

Biol Blood Marrow Transplant. 2009 Feb;15(2):137-72. doi: 10.1016/j.bbmt.2008.12.003. Review. Erratum in: Biol Blood Marrow Transplant. 2009 May;15(5):650.

11.

[Myelodysplastic syndromes or refractory anemias].

Fenaux P.

Rev Prat. 1993 Jun 1;43(11):1379-85. Review. French.

PMID:
8235387
12.

Myelodysplastic syndromes: disease overview and therapy options.

Coutré S.

Manag Care. 2008 Jul;17(7 Suppl 6):3-8. Review.

13.
14.

Emerging therapeutic strategies for myelodysplastic syndrome.

Barrett J, Battiwalla M.

Curr Hematol Rep. 2003 May;2(3):193-201. Review.

PMID:
12901340
15.

Chronic myelomonocytic leukemia: lost in classification?

Bowen DT.

Hematol Oncol. 2005 Mar;23(1):26-33. Review.

PMID:
16149105
16.

Myelodysplastic syndromes.

Scott BL, Deeg HJ.

Annu Rev Med. 2010;61:345-58. doi: 10.1146/annurev.med.051308.132852. Review.

PMID:
20059342
17.

Myelodysplasia.

Heaney ML, Golde DW.

N Engl J Med. 1999 May 27;340(21):1649-60. Review. No abstract available.

PMID:
10341278
18.
19.

Pathogenesis and clinical variations in the myelodysplastic syndromes.

Jacobs A, Clark RE.

Clin Haematol. 1986 Nov;15(4):925-51. Review. No abstract available.

PMID:
3552349
20.

[Diagnosis and treatment for myelodysplastic syndrome (MDS)].

Tamura J, Kawada E, Sato M, Moridaira K, Ito K.

Nihon Ronen Igakkai Zasshi. 2006 Jul;43(4):431-2. Review. Japanese. No abstract available.

PMID:
16937924

Supplemental Content

Support Center